BBC consultants perform ongoing surveillance of the worldwide IVD Diabetes (Device) Management market, including Whole Blood Glucose (WBG) monitoring, Insulin Infusion Pump (IIP) therapy, Continuous Glucose Monitoring (CGM), along with other therapies. The consultants follow competitive developments of the major players (Abbott, Ascensia, Dexcom, Insulet, LifeScan, Medtronic and Roche), along with continuing advancements from secondary competitors. Surveillance of market development activities and dynamics spans across the U.S., EMEA, Asia Pacific, and Latin America. In total, our consultants monitor more than 20 of the most critical individual country markets in this sector. We leverage our years of experience to place into context breaking developments—giving our clients a look at tomorrow, today.


WBG Monitoring
Analysis of $7B worldwide market, including size, growth and share across five regions

Analysis of $1B worldwide market, including major players and developments with the artificial pancreas

Analysis of $2B worldwide market, including major and secondary players

Other Therapies
Analysis of other device management tools, such as non-invasive and mobile health tools, as well as pharmaceutical categories (Insulin, OADs)


Advanced Technologies and Treatments for Diabetes (ATTD)
American Association of Diabetes Educators (AADE)
American Diabetes Association (ADA)
Diabetes Technology Meeting (DTM)
Diabetes UK Professional Conference
European Association for the Study of Diabetes (EASD)
German Diabetes Association (DDG)